One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Both sources print indexed CrCl. Do not silently replace it with an unindexed cutoff or combine this initiation schedule with acute conversion dosing.
What to reconcile: Confirm the exact product, indication, renal measure and full source before prescribing.
Open this note and its source referencesConfirm the exact product, indication, renal measure and full source before prescribing.
Dialysis evidence: Removal information only - not a dialysis regimen
Use frequent plasma-level monitoring in severe renal impairment. Increase cautiously only after levels plateau; a new steady state may take longer than 4 days.
Proarrhythmia, conduction disease, structural heart disease and interaction precautions require specialist assessment. Hemodialysis is not effective for removal; no replacement dose is inferred.
| Printed indexed CrCl, mL/min/1.73 m2 | Source-specific dose / instruction |
|---|---|
| <=35 | 100 mg once daily OR 50 mg twice daily |
| Less severe renal disease | 100 mg every 12 hours |
Flecainide - source renal initial dosing
| Printed indexed CrCl, mL/min/1.73 m2 | Source-specific dose / instruction |
|---|---|
| <=35 | 100 mg once daily OR 50 mg twice daily |
| Less severe renal disease | 100 mg every 12 hours |
Use frequent plasma-level monitoring in severe renal impairment. Increase cautiously only after levels plateau; a new steady state may take longer than 4 days.
Proarrhythmia, conduction disease, structural heart disease and interaction precautions require specialist assessment. Hemodialysis is not effective for removal; no replacement dose is inferred.
RDM63-official-flecainide-8cf840e2e5-C1 · Source locator: Dosage in renal impairment; plasma-level monitoring; warnings; dialysis removal
Use frequent plasma-level monitoring in severe renal impairment. Increase cautiously only after levels plateau; a new steady state may take longer than 4 days.
Proarrhythmia, conduction disease, structural heart disease and interaction precautions require specialist assessment. Hemodialysis is not effective for removal; no replacement dose is inferred.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=flecainide&s1=RDM63-official-flecainide-8cf840e2e5&h1=75315949f8d9e18b47d2d5bdddd8ea6c3ee23348d3e2c1c4c7e52abf0b4f825a